[1]
M. J. Pua, R. M. . Santiago, J. J. Andal, and D. . Ang, “Programmed Death Ligand 1 (PD-L1) Expression and its Association with Driver Mutations among Patients with Non-Small Cell Lung Cancer in a Private Tertiary Care Setting”, Phil Journal Path, vol. 7, no. 2, pp. 36–45, Dec. 2022.